Navigation Links
Minimally Invasive Treatment Offers Hope for Liver Cancer Patients
Date:3/13/2008

In 2007, over 85% of liver cancer treatments performed in interventional

radiology suites used transcatheter chemoembolization, according to

Millennium Research Group

WALTHAM, Mass., March 13 /PRNewswire/ -- Data from Millennium Research Group's (MRG's) US Interventional Radiology (IR) Marketrack(TM) indicates that in 2007, over 85% of liver cancer treatments performed in IR suites used transcatheter chemoembolization, a procedure that delivers chemotherapy agents directly to a tumor through minimally invasive means.

Microsphere particles, including Boston Scientific's Contour SE, Biosphere Medical's Embosphere, and others, were used in 40% of these treatments. Overall, chemoembolization particles generated nearly 20% of total microsphere revenue. As such, chemoembolization procedures are a key segment in the overall embolic particle market, which, in addition to standard microspheres, includes drug-infused microspheres, selective internal radiation therapy (SIRT) spheres, and polyvinyl alcohol (PVA) particles. MRG's US IR Marketrack(TM) service monitors the adoption of embolic particles for liver cancer, uterine fibroids, aneurysms, hemorrhages, and vascular anomalies.

"In chemoembolization, chemotherapy agents are mixed with embolic particles and are delivered through a catheter directly to the tumor, thereby localizing the chemo treatment" says Phil Scrutton, Analyst at MRG. "The particles also embolize the surrounding arteries, blocking blood flow to the cancerous tissue. This slows diffusion of the chemotherapy agents away from the tumor, which increases its effectiveness in targeting the liver tumor, while the embolization also deprives the tumor of oxygen and nutrients."

Liver cancer has historically had a poor prognosis, but the use of embolic particles in conjunction with drugs in chemoembolization, while not a cure, is leading to longer life expectancies for cancer sufferers. These positive
'/>"/>

SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Microfabrica Introduces Set of Miniature Building Blocks for Minimally-Invasive Medical Devices
2. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
3. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
4. InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors
5. Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting
6. Masimo Announces Continuous Noninvasive Total Hemoglobin
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...YORK, Dec. 2 Reportlinker.com anno...le in its catalogue: ,, Neurostimulation - A G...linker.com/p0164232/Neurostimulation---A-Global-Ma...lation market stands enthused by the growing base ...-related diseases such as, Parkinson,s, and Alzhei...
(Date:12/2/2009)... Calif., Dec. 2 Peregrin...orted completion of patient enrollment in a dose c... patients with relapsed glioblastoma multiforme (G...s a targeted monoclonal antibody linked to a radio...nt for GBM. Cotara specifically targets cells at ...
(Date:12/2/2009)... JERUSALEM, Israel, December 2 Gam...ating the preclinical (animal study) safety and,ef...chnology from Weill,Cornell Medical College and Ga... inherited anemias such as Cooley,s Anemia. ,...ogies to expand, ex vivo,populations of stem/prog...
(Date:12/2/2009)...NGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is go...rmoil and uncertainty is part of many,businesses a...ry has been,relatively immune to the economic down..., During the midst of the difficult times th...hnson inaugurated an R&D center in Shanghai, t...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...7 Earnings Conference Call Thursday, November 8, 2... FRAZER, Pa., Oct. 1 Cephalon, Inc. (Nasdaq:,CEP...nference call covering,third quarter 2007 results ... November 8, 2007 Schedule, ...d by PRNewswire 4:50 p.m. EST To participate in...
...t. 1 A highly sensitive, easy-to-use,test that ac...) was,selected as the Best New Veterinary Product ... BoVir(R) BVDV real time PCR test was selected for...udging panel representing,members of the global co...ssionals. The award was presented September 25, 20...
...ment - Guaranteed Purchase Requi...Manufacturing of DaySpring Core ...nge Between $4.4M-7M Over Five Years, IRVING, Tex...eets: CARN) ( http://www.CarringtonLabs.com ),toda...nced multi-year,supply and distribution term sheet...
Other Biology Technology:BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards 2BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards 3Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market 2Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market 3
(Date:12/2/2009)...ef, peanut butter, and other foods have done more ... safety. They also are quietly fueling a boom in t... new food safety regulations. That,s the topic of ...Chemical & Engineering News , (C&EN) ACS, weekly n...sley and Senior Correspondent Marc Reisch point ou...
(Date:12/2/2009)...ised of undergraduate students from Stevens Instit...onal poster contest hosted by the International So...he annual contest highlights the research conducte...SPE Annual Meeting in San Diego, Calif. , The wi...iciate Ligament Tensioning Device," was presented ...
(Date:12/2/2009)...it have a higher IQ and are more likely to go on t...t at the Sahlgrenska Academy and Sahlgrenska Unive...ay in the prestigious Proceedings of the National... 1.2 million Swedish men doing military service wh...oup analysed the results of both physical and IQ t...
Breaking Biology News(10 mins):Young adults who exercise get higher IQ 2Former NFL Quarterback to Speak at Local Nonprofit Fundraising Event 57936 1Former NFL Quarterback to Speak at Local Nonprofit Fundraising Event 57936 2ACUVUE 28R 29 Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 57931 1ACUVUE 28R 29 Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 57931 2ACUVUE 28R 29 Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 57931 3CutisPharma Launches New Prescription Mouthwash Kit Adding to Product Line 57928 1CutisPharma Launches New Prescription Mouthwash Kit Adding to Product Line 57928 2
... (Great Neck, NY, Sept. 2, 2008) People concerne...taking on their families and communities will have...erts on what is known to-date about the causes, sy...sion, bipolar disorder, anxiety, schizophrenia and...atments. , In an unprecedented event called Healt...
... Dr Dick James from the University,s Department o...gists explaining how social network analysis, a me...nteractions among people, can be used to study soc...tionally, students of animal behaviour have looked...or at global behaviours of populations; however us...
..., Scientists at Penn State have developed a new c...o understand how life began on Earth. The team,s ... histories of proteins all the way back to either ...d for all over which of these life forms came firs... of this method," said Randen Patterson, a Penn St...
Other Biology News:Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 3Scientists develop new method to investigate origin of life 2Scientists develop new method to investigate origin of life 3
...loning of BAC (100+kb), fosmid (40kb), and large p...lity than any othe BAC vector. On command 20-50 fo...ombinant DNA purification. Available with blue-whi...RT VC) vectors for the highest insert stability. K...
ApoStat Intracellular Caspase Detection (FITC-VD-FMK) from R&D Systems
Mouse Anti-Rat RT1Bu (Class II Polymorphic) Monoclonal Antibody, Biotin Conjugated from AbD Serotec
Mouse Anti-Guinea Pig T-Cells, Pan Monoclonal Antibody, FITC Conjugated from AbD Serotec
Biology Products: